Sopharma AD (WSE: SPH)
Poland
· Delayed Price · Currency is PLN
13.55
+1.05 (8.40%)
Jan 20, 2025, 1:33 PM CET
Sopharma AD Revenue
Sopharma AD had revenue of 543.31M BGN in the quarter ending September 30, 2024, with 17.45% growth. This brings the company's revenue in the last twelve months to 2.05B, up 12.18% year-over-year. In the year 2023, Sopharma AD had annual revenue of 1.89B with 12.95% growth.
Revenue (ttm)
2.05B BGN
Revenue Growth
+12.18%
P/S Ratio
n/a
Revenue / Employee
435.24K BGN
Employees
4,721
Market Cap
2.07B PLN
Revenue Chart
* This company reports financials in BGN.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.89B | 216.43M | 12.95% |
Dec 31, 2022 | 1.67B | 60.17M | 3.73% |
Dec 31, 2021 | 1.61B | 165.21M | 11.42% |
Dec 31, 2020 | 1.45B | 158.02M | 12.27% |
Dec 31, 2019 | 1.29B | 100.28M | 8.44% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.34B |
Synektik Spólka Akcyjna | 624.80M |
Voxel | 492.41M |
Celon Pharma | 209.54M |
Selvita | 334.42M |
Ryvu Therapeutics | 91.18M |
Centrum Medyczne ENEL-MED | 680.32M |
Mercator Medical | 488.78M |